Peak6 Investments LLC Galapagos Nv Call Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	BUY	$51.32 - $68.5 $2.5 Million - $3.34 Million	48,700 New	48,700 $3.02 Million
Q4 2021 Feb 11, 2022	SELL	$47.03 - $57.12 $1.18 Million - $1.43 Million	-25,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$76.15 - $111.94 $1.52 Million - $2.24 Million	20,000 Added 400.0%	25,000 $1.93 Million
Q4 2020 Feb 12, 2021	BUY	$96.85 - $148.25 $484,250 - $741,250	5,000 New	5,000 $495,000
Q1 2020 May 14, 2020	SELL	$143.0 - $274.03 $157,300 - $301,432	-1,100 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$146.12 - $215.82 $715,988 - $1.06 Million	-4,900 Reduced 81.67%	1,100 $228,000
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $668,700 - $773,580	6,000 New	6,000 $774,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.85B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.